PMDA drug package insert
アロカリス点滴静注235mg
PMDA Prescription drug · 大鵬薬品工業株式会社 · package insert Jun 24, 2025
Key facts
| Brand names | アロカリス点滴静注235mg |
|---|---|
| Nonproprietary names | ホスネツピタント塩化物塩酸塩 |
| Companies | 製造販売元／大鵬薬品工業株式会社, 提携先／HELSINN |
| Product type | Prescription drug |
| Therapeutic category | 選択的NK1受容体拮抗型制吐剤 |
| Therapeutic category codes | 872391 |
| YJ codes | 2391406A1029 |
| Approval numbers | 30400AMX00182000 |
| Package insert edition | 第3版 |
| Package insert date | Jun 24, 2025 |
| PMDA document key | 400107_2391406A1029_1 |
| PMDA company code | 400107 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: